Internal Medicine, Endocrinology, Diabetes, & Metabolism · New York, NY
NPI
1508933151
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
180 Fort Washington Ave
New York, NY, 10032
Phone (212) 305-6238
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,767
86 services
Medicare patients, 2024
45
Average age 72
Drug cost, 2024
$770K
295 prescriptions
Company payments, 2025
$1,700
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pamela U Freda was code 99214 (office e&m - established), 23 times for 21 patients. In total Pamela U Freda billed 86 services in 11 codes, and Medicare paid $7,767.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 23 | 21 | $103.21 | $2,374 |
By year: 2022 $5,134 for 48 services; 2023 $6,329 for 47 services; 2024 $7,767 for 86 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pamela U Freda prescribed most often to Medicare patients was Cabergoline, with 57 prescriptions and refills. In total Pamela U Freda wrote 295 Medicare prescriptions that cost $770K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cabergoline Generic | 57 | 87 | Under 11 | $3,005 |
| Levothyroxine Sodium Generic | 54 | 124 | 13 | $514 |
| Hydrocortisone Generic | 41 | 62 | Under 11 | $992 |
| Somavert Pegvisomant | 40 | 40 | Under 11 | $533K |
| Testosterone Generic | 28 | 43 | Under 11 | $4,514 |
| Genotropin Somatropin | 15 | 15 | Under 11 | $20K |
| Isturisa Osilodrostat Phosphate | 13 | 13 | Under 11 | $177K |
| Synthroid Levothyroxine Sodium | 13 | 38 | Under 11 | $1,811 |
Brand drugs: 100 claims; generic drugs: 195 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pamela U Freda $1,700 ($300 in general payments such as food, travel and fees and $1,400 for research) from 3 companies. The largest payer was Pfizer Inc. with $1,400.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $1,400 |
| Chiesi USA, Inc. | 1 | $300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.